Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Lopez

Showing results (281-290 of 369) with videos related to

Pageof 37
Sort By:
Cancers|February 13, 2020
Uncovering Tumour Heterogeneity through PKR and nc886 Analysis in Metastatic Colon Cancer Patients Treated with 5-FU-Based ChemotherapyMaría Belén Ortega-García, Alberto Mesa, Elisa L J Moya, et al.
Cell Reports|March 12, 2014
Autocrine effects of tumor-derived complementMin Soon Cho, Hernan G Vasquez, Rajesha Rupaimoole, et al.
Cell Reports|November 3, 2021
RNA-binding protein FXR1 drives cMYC translation by recruiting eIF4F complex to the translation start siteJasmine George, Yongsheng Li, Ishaque P Kadamberi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2015
Adrenergic Stimulation of DUSP1 Impairs Chemotherapy Response in Ovarian CancerYu Kang, Archana S Nagaraja, Guillermo N Armaiz-Pena, et al.
Molecular Therapy. Nucleic Acids|January 18, 2019
The Modulatory Role of MicroRNA-873 in the Progression of KRAS-Driven CancersHamada A Mokhlis, Recep Bayraktar, Nashwa N Kabil, et al.
Hereditas|December 21, 2024
Inhibition of microRNA-660-5p decreases breast cancer progression through direct targeting of TMEM41BValeria Villarreal-García, José Roberto Estupiñan-Jiménez, Vianey Gonzalez-Villasana, et al.
Journal of the American Chemical Society|May 14, 2021
Conversion of RNA Aptamer into Modified DNA Aptamers Provides for Prolonged Stability and Enhanced Antitumor ActivityPaola Amero, Ganesh L R Lokesh, Rajan R Chaudhari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2011
Functional roles of Src and Fgr in ovarian carcinomaHye-Sun Kim, Hee Dong Han, Guillermo N Armaiz-Pena, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 18, 2015
Rac1/Pak1/p38/MMP-2 Axis Regulates Angiogenesis in Ovarian CancerVianey Gonzalez-Villasana, Enrique Fuentes-Mattei, Cristina Ivan, et al.
Cancer Biology & Therapy|April 28, 2009
Dual targeting of EphA2 and FAK in ovarian carcinomaMian M K Shahzad, Chunhua Lu, Jeong-Won Lee, et al.
Pageof 37

Showing results (281-290 of 369) with videos related to

Sort By:
Pageof 37
Cancers|February 13, 2020
Uncovering Tumour Heterogeneity through PKR and nc886 Analysis in Metastatic Colon Cancer Patients Treated with 5-FU-Based ChemotherapyMaría Belén Ortega-García, Alberto Mesa, Elisa L J Moya, et al.
Cell Reports|March 12, 2014
Autocrine effects of tumor-derived complementMin Soon Cho, Hernan G Vasquez, Rajesha Rupaimoole, et al.
Cell Reports|November 3, 2021
RNA-binding protein FXR1 drives cMYC translation by recruiting eIF4F complex to the translation start siteJasmine George, Yongsheng Li, Ishaque P Kadamberi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2015
Adrenergic Stimulation of DUSP1 Impairs Chemotherapy Response in Ovarian CancerYu Kang, Archana S Nagaraja, Guillermo N Armaiz-Pena, et al.
Molecular Therapy. Nucleic Acids|January 18, 2019
The Modulatory Role of MicroRNA-873 in the Progression of KRAS-Driven CancersHamada A Mokhlis, Recep Bayraktar, Nashwa N Kabil, et al.
Hereditas|December 21, 2024
Inhibition of microRNA-660-5p decreases breast cancer progression through direct targeting of TMEM41BValeria Villarreal-García, José Roberto Estupiñan-Jiménez, Vianey Gonzalez-Villasana, et al.
Journal of the American Chemical Society|May 14, 2021
Conversion of RNA Aptamer into Modified DNA Aptamers Provides for Prolonged Stability and Enhanced Antitumor ActivityPaola Amero, Ganesh L R Lokesh, Rajan R Chaudhari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2011
Functional roles of Src and Fgr in ovarian carcinomaHye-Sun Kim, Hee Dong Han, Guillermo N Armaiz-Pena, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 18, 2015
Rac1/Pak1/p38/MMP-2 Axis Regulates Angiogenesis in Ovarian CancerVianey Gonzalez-Villasana, Enrique Fuentes-Mattei, Cristina Ivan, et al.
Cancer Biology & Therapy|April 28, 2009
Dual targeting of EphA2 and FAK in ovarian carcinomaMian M K Shahzad, Chunhua Lu, Jeong-Won Lee, et al.
Pageof 37